tiprankstipranks
Bicycle Therapeutics Welcomes Stephen Sands to Board
PremiumCompany AnnouncementsBicycle Therapeutics Welcomes Stephen Sands to Board
2M ago
Bicycle Therapeutics reports Q4 EPS ($1.16), consensus ($1.23)
PremiumThe Fly
Bicycle Therapeutics reports Q4 EPS ($1.16), consensus ($1.23)
2M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
Bicycle Therapeutics price target lowered to $43 from $46 at Needham
PremiumThe FlyBicycle Therapeutics price target lowered to $43 from $46 at Needham
4M ago
Bicycle Therapeutics to host research and development day
PremiumThe Fly
Bicycle Therapeutics to host research and development day
4M ago
Bicycle Therapeutics updates clinical programs at first ‘R&D Day’
PremiumThe Fly
Bicycle Therapeutics updates clinical programs at first ‘R&D Day’
4M ago
Cantor biotech/biopharma analysts hold analyst/industry conference call
PremiumThe FlyCantor biotech/biopharma analysts hold analyst/industry conference call
5M ago
Cantor biotech/biopharma analysts hold analyst/industry conference call
PremiumThe Fly
Cantor biotech/biopharma analysts hold analyst/industry conference call
6M ago
Bicycle Therapeutics aligned with FDA on registration trial for  BT8009
PremiumThe Fly
Bicycle Therapeutics aligned with FDA on registration trial for BT8009
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100